A murine model of FGFR2 fusion driven intrahepatic cholangiocarcinoma to delineate the mechanism of therapeutic response and resistance to FGFR inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Anmerkungen
-
Hannover, Medizinische Hochschule Hannover, Dissertation, 2021
- Schlagwort
-
Bile ducts--Cancer
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wer)
-
Bibliothek der Medizinischen Hochschule Hannover
- (wann)
-
2021
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.26068/mhhrpm/20210426-007
- URN
-
urn:nbn:de:101:1-2021070813102614159734
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kendre, Gajanan Bhujangrao
- Vogel, Arndt
- Lehmann, Ulrich
- Klinik für Gastroenterologie, Hepatologie und Endokrinologie
- Bibliothek der Medizinischen Hochschule Hannover
Entstanden
- 2021
Ähnliche Objekte (12)
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma
Correction to: The focus clinical research in intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma with a liver abscess due to hepatic actinomycosis
Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants
Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma
The focus clinical research in intrahepatic cholangiocarcinoma
Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma
Prognostic factors in patients with intrahepatic cholangiocarcinoma
Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma
Correction to: The focus clinical research in intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma with a liver abscess due to hepatic actinomycosis
Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants
Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma
The focus clinical research in intrahepatic cholangiocarcinoma
Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma
Prognostic factors in patients with intrahepatic cholangiocarcinoma
Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma
Correction to: The focus clinical research in intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma with a liver abscess due to hepatic actinomycosis
Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants
Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma
The focus clinical research in intrahepatic cholangiocarcinoma
Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma
Prognostic factors in patients with intrahepatic cholangiocarcinoma